AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Metzuk-G 2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Mizukhi's Pharmaa

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Metzuk-G 2 Tablet SR

GlucoDuo SR tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. GlucoDuo SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are vital for effective diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, manifesting as sweating, dizziness, headache, or tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician prior to initiation. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Metzuk-G 2 Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Metzuk-G 2 Tablet SR

Managing type 2 diabetes

Major Benefits of Metzuk-G 2 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metzuk-G 2 Tablet SR should be administered with a meal.

Common Side effects of Metzuk-G 2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metzuk-G 2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metzuk-G 2 Tablet SR whole; do not crush, chew, or break it. Administer this medication with a meal.

How Metzuk-G 2 Tablet SR works:

Metformin and Glimepiride, combined as Metzuk-G 2 Tablet SR, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Metzuk-G 2 Tablet SR use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metzuk-G 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Concurrent use of Metzuk-G 2 Tablet SR and breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Metzuk-G 2 Tablet SR, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Metzuk-G 2 Tablet SR. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metzuk-G 2 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is usually prescribed for those with mild to moderate liver disease; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Metzuk-G 2 Tablet SR :

Should you forget a Metzuk-G 2 Tablet SR dose, take it immediately if you remember. However, near your next scheduled dose, omit the missed one and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Metzuk-G 2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metzuk-G 2 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metzuk-G 2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Metzuk-G 2 Tablet SR and seek immediate medical attention.
Metzuk-G 2 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Metzuk-G 2 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Metzuk-G 2 Tablet SR can lead to Vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental Vitamin B12 is recommended at least annually by some researchers.
Metzuk-G 2 Tablet SR can cause low blood sugar (hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metzuk-G 2 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Metzuk-G 2 Tablet SR
78
MRP 90
13% off